Mallat MJ - Search Results

1

Delayed graft function influences renal function but not survival.

Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Boom H, et al. Among authors: mallat mj. Transplant Proc. 2001 Feb-Mar;33(1-2):1291. doi: 10.1016/s0041-1345(00)02482-9. Transplant Proc. 2001. PMID: 11267296 No abstract available.

2

Patient survival after renal transplantation; more than 25 years follow-up.

Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA. Arend SM, et al. Among authors: mallat mj. Nephrol Dial Transplant. 1997 Aug;12(8):1672-9. doi: 10.1093/ndt/12.8.1672. Nephrol Dial Transplant. 1997. PMID: 9269647

3

Sharing cross-reactive groups of MHC class I improves long-term graft survival.

Sijpkens YW, Doxiadis II, De Fijter JW, Mallat MJ, van Es LA, De Lange P, Zwinderman AH, Westendorp RG, van Kemenade FJ, Bruijn JA, Claas FH, Paul LC. Sijpkens YW, et al. Among authors: mallat mj. Kidney Int. 1999 Nov;56(5):1920-7. doi: 10.1046/j.1523-1755.1999.00753.x. Kidney Int. 1999. PMID: 10571803 Free article.

4

Delayed graft function influences renal function, but not survival.

Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Boom H, et al. Among authors: mallat mj. Kidney Int. 2000 Aug;58(2):859-66. doi: 10.1046/j.1523-1755.2000.00235.x. Kidney Int. 2000. PMID: 10916111 Free article.

5

Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.

Sijpkens YW, Mallat MJ, Siegert CE, Zwinderman AH, Westendorp RG, de Fijter JW, van Es LA, Paul LC. Sijpkens YW, et al. Among authors: mallat mj. Clin Nephrol. 2001 Feb;55(2):149-55. Clin Nephrol. 2001. PMID: 11269679

6

Increased immunogenicity and cause of graft loss of old donor kidneys.

Fijter JW, Mallat MJK, Doxiadis IIN, Ringers J, Rosendaal FR, Claas FHJ, Paul LC. Fijter JW, et al. J Am Soc Nephrol. 2001 Jul;12(7):1538-1546. doi: 10.1681/ASN.V1271538. J Am Soc Nephrol. 2001. PMID: 11423584

7

Early versus late acute rejection episodes in renal transplantation.

Sijpkens YW, Doxiadis II, Mallat MJ, de Fijter JW, Bruijn JA, Claas FH, Paul LC. Sijpkens YW, et al. Among authors: mallat mj. Transplantation. 2003 Jan 27;75(2):204-8. doi: 10.1097/01.TP.0000041722.34000.21. Transplantation. 2003. PMID: 12548124

8

Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.

Bakker RC, Hollander AA, Mallat MJ, Bruijn JA, Paul LC, de Fijter JW. Bakker RC, et al. Among authors: mallat mj. Kidney Int. 2003 Sep;64(3):1027-34. doi: 10.1046/j.1523-1755.2003.00175.x. Kidney Int. 2003. PMID: 12911553 Free article. Clinical Trial.

9

Calcium levels as a risk factor for delayed graft function.

Boom H, Mallat MJ, de Fijter JW, Paul LC, Bruijn JA, van Es LA. Boom H, et al. Among authors: mallat mj. Transplantation. 2004 Mar 27;77(6):868-73. doi: 10.1097/01.tp.0000116417.03114.87. Transplantation. 2004. PMID: 15077029

10

An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.

van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR. van der Boog PJ, et al. Nephrol Dial Transplant. 2004 Oct;19(10):2487-93. doi: 10.1093/ndt/gfh394. Epub 2004 Jul 13. Nephrol Dial Transplant. 2004. PMID: 15252166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters